Ceryvyn Therapeutics Limited (ASX:CYV)

Australia · Delayed Price · Currency is AUD

0.0100

0.00 (0.00%)

Sep 18, 2026, 4:10 PM AEST

Ceryvyn Therapeutics Financials Overview

Financials in millions AUD. Fiscal year is July - June.

Millions AUD. Fiscal year is Jul - Jun.

Revenue & Profits

Fiscal Year	TTM	FY 2026	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	Jun '26 Jun 30, 2026	Jun '26 Jun 30, 2026	Jun '25 Jun 30, 2025	Jun '24 Jun 30, 2024	Jun '23 Jun 30, 2023	Jun '22 Jun 30, 2022
Revenue	0	0	0.23	0.39	0.58	0.29
Revenue Growth	-	-99.56%	-41.94%	-32.16%	100.42%	126.61%
Gross Profit	0	0	0.23	0.39	0.58	0.06
Operating Income	-11.95	-11.95	-241.78	-287.53	-225.41	-140.12
Net Income	330.45	330.45	-251.15	-330.1	-214.14	-134.72
Earnings Per Share	0.24	0.24	-0.21	-0.52	-0.48	-0.38
EPS Growth	5.60%	-	-	-	-	-

Cash & Debt

Fiscal Year	Current	FY 2026	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	Jun '26 Jun 30, 2026	Jun '26 Jun 30, 2026	Jun '25 Jun 30, 2025	Jun '24 Jun 30, 2024	Jun '23 Jun 30, 2023	Jun '22 Jun 30, 2022
Cash & Investments	30.02	30.02	73.94	258.5	134.01	64.78
Total Debt	-	-	377.01	300.7	128.98	-
Net Cash (Debt)	30.02	30.02	-303.07	-42.2	5.03	64.78
Net Cash Growth	-9.49%	-	-	-	-92.24%	-58.87%
Net Cash Per Share	0.02	0.02	-0.25	-0.07	0.01	0.18

Cash Flow & CapEx

Fiscal Year	TTM	FY 2026	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	Jun '26 Jun 30, 2026	Jun '26 Jun 30, 2026	Jun '25 Jun 30, 2025	Jun '24 Jun 30, 2024	Jun '23 Jun 30, 2023	Jun '22 Jun 30, 2022
Operating Cash Flow	-12.5	-12.5	-244.74	-241.33	-181.21	-103.54
Capital Expenditures	-	-	-0.02	-0.05	-0.03	-0.02
Free Cash Flow	-12.5	-12.5	-244.76	-241.38	-181.25	-103.56
Free Cash Flow Growth	-	-	-	-	-	-

Margins

Fiscal Year	TTM	FY 2026	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	Jun '26 Jun 30, 2026	Jun '26 Jun 30, 2026	Jun '25 Jun 30, 2025	Jun '24 Jun 30, 2024	Jun '23 Jun 30, 2023	Jun '22 Jun 30, 2022
Gross Margin	100.00%	100.00%	100.00%	100.00%	100.00%	19.35%
Operating Margin	-1194700.00%	-1194700.00%	-106042.98%	-73222.06%	-38939.90%	-48510.38%
Pretax Margin	33023600.00%	33023600.00%	-114856.14%	-87654.11%	-38530.23%	-49806.09%
Profit Margin	33044500.00%	33044500.00%	-110151.75%	-84061.75%	-36992.02%	-46640.70%
FCF Margin	-1249800.00%	-1249800.00%	-107348.68%	-61468.64%	-31310.17%	-35854.29%

Valuation

Fiscal Year	Current	FY 2026	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	Sep '26 Sep 18, 2026	Jun '26 Jun 30, 2026	Jun '25 Jun 30, 2025	Jun '24 Jun 30, 2024	Jun '23 Jun 30, 2023	Jun '22 Jun 30, 2022
PE Ratio	0.04	0.06	-	-	-	-
Forward PE	-	109.83	109.83	109.83	109.83	109.83
PS Ratio	13679.78	20519.67	3240.23	972.82	443.86	1341.13